Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
A woman developed amenorrhoea and galactorrhoea after partial removal of a pituitary tumor during pregnancy. Hyperprolactinaemia was supressed by therapy with bromocryptine (CB 154, Sandoz) resulting in cessation of galactorrhoea in two months, spontaneous menstruation after eight months, and pregnancy after twelve months.
D000238:Adenoma, Chromophobe / Q000150:complications*; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy* / Q000209:etiology; D001971:Bromocriptine / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007775:Lactation Disorders / Q000188:drug therapy*; D010911:Pituitary Neoplasms / Q000150:complications*; D011247:Pregnancy; D013577:Syndrome
D004873:Ergolines; D001971:Bromocriptine